Alvogen Malta Operations

Alvogen is a global pharmaceutical company focused on developing, manufacturing, and selling generic, brand, over-the-counter (OTC), and biosimilar products. The company operates a complex supply chain and manufacturing network, with Alvogen Malta Operations serving as a critical hub for its European and international business activities, including regulatory affairs and marketing authorizations. Alvogen's portfolio covers a broad range of therapeutic areas such as oncology, cardiology, and neurology, with a significant emphasis on high-barrier generics and biosimilars. Through its subsidiaries and strategic partnerships, the company maintains a presence in over 35 countries, leveraging a hybrid business model that combines internal R&D with a robust B2B licensing platform.